LISATA THERAPEUTICS, INC. Lessee, Operating Lease, Liability, to be Paid, Year One
LISATA THERAPEUTICS, INC. (LSTA) had Lessee, Operating Lease, Liability, to be Paid, Year One of $143.00 thousand as of 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2025-02-27
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $143.00K.
- 2024-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $143.00K.
- 2024-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $143.00K.
- 2024-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $143.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2024-12-31 | $143.00K 10-K · filed 2025-02-27 |
| 2024-09-30 | $143.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $143.00K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $143.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $190.00K 10-K · filed 2024-02-29 |
| 2023-09-30 | $190.00K 10-Q · filed 2023-11-02 |
| 2023-06-30 | $190.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $190.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $217.00K 10-K · filed 2023-03-30 |
| 2022-09-30 | $217.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $217.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $217.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $286.00K 10-K · filed 2022-03-22 |
| 2021-09-30 | $239.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $239.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $239.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $414.00K 10-K · filed 2021-02-25 |
| 2020-09-30 | $414.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $414.00K 10-Q · filed 2020-08-13 |
| 2019-12-31 | $431.00K 10-K · filed 2020-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |